Understanding the role of DIMT1 in blood cell development
Catalytic roles of RNA methyltransferase DIMT1
This study is looking at how a specific enzyme called DIMT1 helps in the growth and function of blood cells, especially by changing a part of the cell's machinery that makes proteins, and it's aimed at understanding its role for people with blood disorders like Fanconi anemia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10875603 on NIH RePORTER |
What this research studies
This research investigates how the enzyme DIMT1 affects the development and function of blood cells, particularly focusing on its role in modifying ribosomal RNA (rRNA). By using advanced techniques like CRISPR screening, the study aims to uncover how DIMT1 influences the viability of hematopoietic stem progenitor cells, which are crucial for producing blood cells. The research seeks to clarify the mechanisms by which DIMT1 contributes to blood cell formation and its potential implications for disorders like Fanconi anemia.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with hematopoietic disorders or those affected by conditions like Fanconi anemia.
Not a fit: Patients with non-hematopoietic disorders or those not affected by blood cell development issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and treatments for blood disorders linked to rRNA modifications.
How similar studies have performed: Previous studies have shown promising results in understanding the roles of rRNA modifications in blood cell development, suggesting that this research builds on established findings.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Liu, Fange — University of Pennsylvania
- Study coordinator: Liu, Fange
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.